SEATTLE, July 26, 2018 /PRNewswire/ -- CTI BioPharma
Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that
management plans to report its second quarter 2018 financial
results on Thursday, August 2, 2018, after the close of the
U.S. financial markets. Following the announcement, members of the
management team will host a webcast conference call to discuss the
results and provide a general corporate update at 4:30 p.m.
ET (1:30 p.m. PT). Access to the
event can be obtained as follows:
Thursday, August 2, 2018
1:30 p.m. PT/4:30 p.m. ET/10:30 p.m.
CET
877-260-1479 (domestic)
+1 334 323 0522 (international)
To access the live audio webcast or the subsequent archived
recording, visit CTI
BioPharma's website, www.ctibiopharma.com. Webcast and
telephone replays of the conference call will be available at
approximately two hours after completion of the call. Callers can
access the replay by dialing 1-888-203-1112 (domestic) or +1
719-457-0820 (international). The access code for the replay is
3255708. The telephone replay will be available
until Thursday, August 9, 2018.
About CTI BioPharma
CTI BioPharma Corp. is a biopharmaceutical company focused on
the acquisition, development and commercialization of novel
targeted therapies covering a spectrum of blood-related cancers
that offer a unique benefit to patients and healthcare providers.
The CTI BioPharma lead product candidate, pacritinib, is being
developed for the treatment of patients with myelofibrosis. CTI
BioPharma is headquartered in Seattle,
Washington.
CTI BioPharma Contacts:
Julia Balanova (investors)
+1 646 378 2936
jbalanova@troutgroup.com
Rich Allan (media)
+1 646 378 2958
rallan@troutgroup.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-report-second-quarter-2018-financial-results-on-august-2-2018-300687286.html
SOURCE CTI BioPharma Corp.